The SA25 Workcell is a gloveless isolator for the automated filling of injectable or lyophilized therapies. The SA25 fills syringes, vials or cartridges. The rapid changeover between formats and the use of nested, pre-sterilized containers increases uptime and supports producing multiple drug products in various container types using the same machine. New products can be developed without the need for additional investment in capital equipment or facility changes.
Faster to Market
The SA25 Aseptic Workcell is ideal for the current pharma market, where there are an increasing number of potent, high-value therapies focused on smaller patient populations. Small molecules, biologics, cell therapies, and cytotoxic products all benefit from the SA25’s tight process control and automation. The SA25 supports technology transfer from clinical trials through post-approval commercial production. This enables pharmaceutical companies to get to market faster by developing production processes earlier in a drug’s life.
The Aseptic Workcell approach has lower facility requirements, is easier to validate and requires fewer operators than conventional filling systems. Operators can be trained more easily because interventions (if any) are done robotically.